Central Asian Research Index

Tibbiyot, ta’lim va innovatsion tadqiqotlar, 2026, т. 2, № 10, с. 675-682

THE COL1A1 1997C/A (RS1107946) GENE POLYMORPHISM IN OSTEOPOROSIS ASSOCIATED WITH CARDIORENAL SYNDROME

Yulduz Isom kizi Nadirova, Laylo Dilshadovna Tursunova

Аннотация · Abstract

Background. Bone strength depends on the organic matrix as well as on mineral content, and type I collagen is its principal protein. The COL1A1 gene encodes the alpha-1 chain of this collagen, and promoter variants alter transcription and the ratio of alpha-1 to alpha-2 chains, thereby affecting bone quality independently of bone mineral density. Aim. In chronic kidney disease (CKD), the bone matrix is already compromised by mineral dysregulation and secondary hyperparathyroidism, while concomitant chronic heart failure (CHF) adds neurohumoral, inflammatory and nutritional burdens. Whether a matrix-related genetic variant becomes phenotypically apparent in this setting has not yet been examined. Materials and Methods. The study enrolled 196 subjects divided into three groups: patients with CHF, CKD and osteoporosis (n = 52); patients with CKD and osteoporosis without clinically significant CHF (n = 48); and healthy volunteers comprising the control group (n = 96). The study assessed calcium-phosphorus metabolism, intact parathyroid hormone, 25-hydroxyvitamin D, serum creatinine, estimated glomerular filtration rate and N-terminal pro-Btype natriuretic peptide. The COL1A1 1997C/A polymorphism (rs1107946) was genotyped by polymerase chain reaction with restriction fragment length polymorphism analysis. Odds ratios and their 95% confidence intervals were calculated using the Woolf method, and statistical significance was assessed using the two-sided Fisher exact test. Results. Genotype distributions conformed to Hardy–Weinberg equilibrium in all groups. The minor A allele was significantly more frequent in both patient groups than in the control group, and the association demonstrated a graded pattern: it was stronger in the group with CHF than in the group without CHF, with a statistically significant difference between the two patient groups. Moreover, heterozygous C/A genotype carriage was overrepresented to almost the same extent in both patient groups, whereas A/A homozygosity was overrepresented only in the group with CHF. In the absence of CHF, the frequency of the A/A genotype did not differ significantly from that in the control group. Conclusion. The A allele of the COL1A1 1997C/A polymorphism acts as a risk marker for osteoporosis in CKD, irrespective of cardiac status, whereas its homozygous form is specifically associated with the cardiorenal phenotype. Consequently, genotype provides an additional, non-fluctuating layer of information alongside mineral indices already used to predict fracture risk in CKD. These findings warrant replication in larger regional cohorts.

Сведения · Details